PRRT retreatment may be well tolerated and confer a survival benefit in patients with well-differentiated, metastatic neuroendocrine tumors, a study suggests.

Thrombotic risk with PICCs matched that of totally implantable venous access devices, showing comparable long-term safety.

POTOMAC supports 1 year of durvalumab with BCG induction and maintenance therapy as a potential new treatment in BCG-naïve, high-risk NMIBC,” said Maria De Santis, MD.

Mindfulness-based interventions beneficial for nurses, midwives, while professional coaching effective for physicians.

Abemaciclib is the first CDK4/6 inhibitor to produce a significant overall survival benefit in patients with hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer, ...

A scoping review identified key factors that ensure an optimal nursing work environment that supports nurses and quality patient care.

The findings suggest that the HER2DX assay could help clinicians decide on the appropriate use of chemotherapy in older patients, study researchers wrote.

Researchers recommend that future studies examine potential associations between survival and genomic mutations, clinical treatment history, and area deprivation index.

Regorafenib-nivolumab “was not superior to investigator’s choice of chemotherapy in third- or later-line treatment,” said David Goldstein, MBBS.

A retrospective study investigated the association of biomarkers pre- and post-cilta cel infusion with neurocognitive TEAEs and cranial nerve palsy in pts with RRMM.

Increase in cultivated land and herbicide-treated acreage independently linked to increase in melanoma incidence.

Cardiac testing identified asymptomatic, clinically significant arrhythmias in 19% of patients on ibrutinib.